BBIO financials
BridgeBio Pharma (BBIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BBIO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $502.08M | $473.81M | -$569.09M | -$729.31M | -3.79 |
| 2024 | $221.90M | $218.02M | -$592.97M | -$535.76M | -2.88 |
| 2023 | $9.30M | $6.86M | -$607.37M | -$643.20M | -3.95 |
| 2022 | $77.65M | $74.21M | -$512.20M | -$481.18M | -3.35 |
| 2021 | $69.72M | $66.60M | -$576.63M | -$562.54M | -3.90 |
| 2020 | $8.25M | $8.25M | -$474.48M | -$448.72M | -4.10 |
- BBIO revenue was $502.08M in fiscal 2025, net income -$729.31M.
Updated 2026-11-02 17:55 UTC